Posts for Category: ACMT News

The Medical Toxicology Foundation and Society for Academic Emergency Medicine Foundation are pleased to announce Simon J. Ostrowski, MD of University of Pittsburgh as the recipient of the 2024 MTF/SAEMF Toxicology Research Grant.

ACMT is thrilled to announce the 2024 - 2026 ANTIDOTE Institute cohort.

Products containing PFAS include firefighting foams, to stain-resistant carpets and fabrics, to fast food packaging, and many others.  Our understanding of health effects related to exposure to these compounds is evolving quickly.

Dr. Powell Graham hs been selected as the 2024 recipient of the Charles E. Becker Medal for Outstanding Achievement as a Medical Toxicology Fellow.

We are pleased to announce the recipients of this award, offered for the first time by ACMT through a collaborative partnership with NIDA. We congratulate Matthew Dernbach, MD, and Anthony Spadaro, MD on being the ingaural awardees.

ACMT is pleased to announce the 2024 ACMT Annual Scientific Meeting (ASM) and Symposia taking place April 10 - 14 at the Omni Shoreham Hotel in Washington, DC.

We are thrilled to announce a significant milestone in ACMT’s online toxicology education efforts with the completion of the ACMT/ALiEM Toxicology Visual Pearls series' 50th post.

ACMT is delighted to introduce our two new Board Members. Dr. Michael Holland and Dr. Shan Yin will begin their board service at the Annual Scientific Meeting in April of 2024. Get to know them more by reading their personal statements

The potential benefits of nalmefene over naloxone carry risk of causing harm. These benefits, if present, should be demonstrated in the clinical environment, balanced with the risks, and compared to naloxone prior to broad adoption of nalmefene.

As the year comes to a close, we would like to take a moment to celebrate a year filled with achievements and growth!